Tag: pharmaceuticals

Bruce Takefman, ResearchFDI Founder and CEO, will discuss the latest foreign direct investment (FDI) trends in emerging sectors during his LiveXchange Emerging Industries General Session.

Lindsay, a two-time Jeopardy! champion—and the only human to go undefeated against IBM’s Watson—will be the keynote speaker at this year's LiveXchange Emerging Industries event.

Pharmaceutical maker Jubilant HollisterStier will also invest $193 million in an expansion of its East Spokane, WA plant.

Arrowhead will receive up to $16M in tax increment financing from the city of Verona, and up to $2.5M in tax credits from the Wisconsin Economic Development Corporation (WEDC).

Business Facilities is expanding its Business Facilities LiveXchange franchise with the introduction of LiveXchange Emerging Industries.

Germany-based pharmaceutical company Boehringer Ingelheim will create 55 jobs at its Animal Health Global Innovation Center in Athens, GA.

Nearly 70 percent of U.S. executives say their companies plan to expand in the next 12 months, up from 58 percent last quarter, finds new AICPA survey.

Successful introduction of mRNA vaccines has created a platform for the rapid development of new treatments.

Transformative drug manufacturer On Demand Pharmaceuticals will locate its new headquarters, manufacturing, and R&D facility in Montgomery County, MD.

Roche will invest $381 million to establish a Global Pharma Technical Operations site at its Canadian pharmaceutical headquarters in Mississauga, Ontario.

The Japan-based pharmaceutical and medical device company cited local industry resources as key to locating its U.S. operations in Montgomery County, MD.

The University of Alabama at Birmingham is collaborating with biopharm company Altimmune for preclinical testing of a potential vaccine to prevent COVID-19 disease.

Iowa has always been an agricultural powerhouse, so it’s no surprise the Cornhusker State is a leader in bioscience with 1,266 firms in the sector, from startups to global leaders in R&D.

The company will invest over $100 million to expand its biologics manufacturing operations in Bloomington, IN.

The $73 million investment is part of wider $1 billion investment that will transform the Darmstadt site into the company’s contemporary global headquarters.

The $76 million investment in Chengdu, Sichuan province confirms China as the third pillar of Sanofi Global Clinical Sciences and Operations, joining facilities in France and the U.S.

Industry analysts are predicting that 2018 will turn out to be a banner year for merger and acquisition activity in the biotech/pharma sector, with up to $200 billion in assets changing hands.

The expansion will create over 200 jobs and make the operation one of the largest laboratories for preclinical and clinical drug development testing in the U.S.

The March / April 2018 Issue features the emerging cybersecurity sector, an exclusive interview with Kentucky Gov. Matt Bevin, plus a look at biopharm, robots, STEM, data centers, and retail.

The pharmaceutical company will expand its capabilities in biologics through a new biotech center at its global headquarters and manufacturing site in St Prex, Switzerland.